eli lilly cease and desist letter tirzepatide OrderlyMeds' Response to Lilly's Cease-and-Desist Eli Lilly Takes Action Against
Description
5 - PMID 37786396 - Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial, JAMA (2023)
no efficacy endpoint expected
Tirzepatide versus semaglutide fatigue Both semaglutide and tirzepatide can cause fatigue, but the mechanisms and patterns differ slightly
J Pers Med
However, they share one thing in common: they can have a profound impact on peoples lives when used correctly and under medical supervision
